Clinical Trials - October 20, 2020
Nanoform starts first-in-human trial
Nanoform will, in the fourth quarter of 2020, start the first ever human trial of a drug candidate nanoformed using its CESS technology. Dosing will begin before year-end 2020 (previously: in 2021) and results are expected before the end of Q2/2021. The clinical trial is a progression of Nanoform’s first GMP campaign, which the company […]
In a new job - September 7, 2020
Nanoform expands its global commercial team
Nanoform has appointed Eric Peter and Sergie Letser to drive the company’s business development in the US. The expansion to Nanoform’s commercial team will give the company a strengthened presence in the US market and enable a continued rate of rapid global growth, it states. Eric Peter Eric Peter will utilize his business development and […]
In a new job - August 13, 2020
Nanoform to elect Cynthia Schwalm as board member
Nanoform Finland will convene an extraordinary general meeting (EGM) on September 1, 2020 at 10 am Helsinki time to elect Cynthia Schwalm as a new board member. Cynthia, a Biotechnology CEO and pharmaceutical leader, began her career as an Oncology and Critical Care Nurse at the Albert Einstein Medical Center & Rutgers University Camden Medical […]
Collaboration - March 9, 2020
Nanoform and Orion collaborate
Nanoform and Orion Corporation have announced a collaboration to apply Nanoform’s CESS technology to new chemical entities. Building on an existing relationship, this collaboration will utilize Nanoform’s CESS technology to improve the bioavailability and solubility of selected early-development compounds, increasing the likelihood of drugs entering clinical development, states the companies. Many new chemical entities struggle […]
In a new job - January 14, 2020
Nanoform has appointed a Head of US Sales
Nanoform has appointed Sally Langa as Head of US Sales, and her new role will enable Nanoform to continue its growth with a strengthened presence in the US market. As Head of US Sales, Langa will drive business development in this key region, states the company. Together with the rest of the commercial team, she […]
Pharma Business - January 8, 2020
Nanoform files for GMP certification
Nanoform has filed for GMP status with the Finnish Medicines Agency, FIMEA. The drug substance application for GMP clinical manufacture certification exemplifies its progress and growth in the last 12 months, states the company. The certification will enable a transition from non-GMP feasibility studies into GMP clinical manufacture, enabling clients to deliver Nanoformed APIs to […]
